PubMed · 12568334
Retrovirus molecular conjugates.
Abstract
Retrovirus-derived vectors are currently the preferred vectors used for human gene therapy protocols. Serious safety concerns persist, however, which are specifically related to the formation of a replication-competent virus, and no synthesis method currently employed precludes its formation with certainty. For many cell types, a low transduction efficiency results in insufficient therapeutic benefit. We describe the development of a molecular conjugate system, which permits transient chemical modification of a retrovirus with polylysine. This modification not only introduces additional safety features over standard unmodified retrovirus vectors, but also provides enhanced transduction efficiency.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Q Zhong, J K Kolls, P Schwarzenberger. 2002. Retrovirus molecular conjugates.. https://doi.org/10.1007/s000180200008
Cite the original work for its findings. Save a collection to share your selection of sources.